Spectral Medical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EDTXF research report →
Price Chart
About the company
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
- CEO
- Chris Seto
- IPO
- 2009
- Employees
- 29
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on EDTXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $234.84M
- P/E
- -8.86
- Fwd P/E
- 40.11
- PEG
- 0.09
- P/S
- 130.21
- P/B
- -4.77
- EV/EBITDA
- -11.10
- Div Yield
- 0.00%
- Gross Margin
- -94.78%
- Op Margin
- -431.14%
- Net Margin
- -1391.98%
- ROE
- 51.23%
- ROIC
- 27.65%
Latest fiscal year · YoY change
- Revenue
- $2.44M+6.7%
- Gross Profit
- $-5,151,797-606.1%
- Op Income
- $-11,675,477
- Net Income
- $-47,653,133-209.4%
- EPS
- $-0.16-190.9%
- OCF Growth
- -8.0%
- FCF Growth
- -9.9%
- 52W High
- $1.15
- 52W Low
- $0.65
- 50D MA
- $0.91
- 200D MA
- $0.97
- Beta
- 0.21
- RSI (14)
- 41
- Avg Volume
- 10.51K
No earnings-call transcripts are available for EDTXF yet.
- Free Float
- 70.5%
- Shares Outstanding
- 293.55M
- Float Shares
- 206.86M
Our EDTXF coverage
Recent articles, reports, and earnings notes.
No research on EDTXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EDTXF report →Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
globenewswire.com · Jun 25
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
globenewswire.com · Jun 9
Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript
seekingalpha.com · Jun 8
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial
globenewswire.com · Jun 4
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
globenewswire.com · May 29
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com · May 8
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
newsfilecorp.com · Apr 1
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
globenewswire.com · Mar 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.